GLP-1 performs several functions in the body, all of which are crucial for the management of glucose levels in the bloodstream, along with appetite regulation
Lilly has been investing in new technologies to improve the LPPS method by optimising the separation of the growing peptide chain
Obesity and Metabolism, 21(4), 389-404
By preventing lipogenesis and promoting lipolysis, glucagon also has lipolytic effects on white adipose tissue [14]
Beyond hormonal changes, several interconnected factors may contribute to perimenopausal weight gain: Metabolic slowdown : Basal metabolic rate naturally decreases with age, meaning the body burns fewer calories at rest Muscle mass loss : Sarcopenia (age-related muscle loss) accelerates during perimenopause, further reducing metabolic rate Sleep disruption : Night sweats and insomnia, common perimenopausal symptoms, interfere with hormones regulating appetite and glucose metabolism Mood changes : Anxiety, depression, and stress during this transition may lead to emotional eating patterns Reduced physical activity : Fatigue, joint pain, and other symptoms may decrease exercise tolerance Research suggests women may gain weight gradually during perimenopause, though individual experiences vary considerably
Theres also a major caveat here: GLP-1s are considered a pregnancy category C medication